journal article·2018-11-07

Multivalent Antibody–Nanoparticle Conjugates To Enhance the Sensitivity of Surface-Enhanced Raman Scattering-Based Immunoassays

Miyeon Lee, Hyeran Kim, Eungwang Kim, So Yeon Yi, Seul Gee Hwang, Siyeong Yang, Eun-Kyung Lim, Bongsoo Kim, Juyeon Jung, Taejoon Kang

ACS Applied Materials & Interfaces· Volume 10· Issue 44
Publisher page

Abstract

Multivalent immunoprobes can improve the sensitivity of biosensors because increased valency can strengthen the binding affinity between the receptor and target biomolecules. Here, we report surface-enhanced Raman scattering (SERS)-based immunoassays using multivalent antibody-conjugated nanoparticles (NPs) for the first time. Multivalent antibodies were generated through the ligation of Fab fragments fused with Fc-binding peptides to immunoglobulin G. This fabrication method is easy and fast because of the elimination of heterologous protein expression, high degrees of antibody modifications, and covalent chemical ligation steps. We constructed multivalent antibody-NP conjugates (MANCs) and employed them as SERS immunoprobes. MANCs improved the sensitivity of SERS-based immunoassays by 100 times compared to standard antibody-NP conjugates. MANCs will increase the feasibility of practical SERS-based immunoassays.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection · Advanced Biosensing Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, KAIST, Daejeon 34141, Korea

Department of Nanobiotechnology, KRIBB School of Biotechnology, UST, Daejeon 34113, Korea

Funding

Korea Research Institute of Bioscience and Biotechnology · National Research Foundation of Korea · Ministry of Environment · Ministry of Science and ICT

References (25)

Show source-provided references
1. 10.1021/acs.chemrev.7b0002710.1021/acs.chemrev.7b00027 ↗
2. 10.1006/meth.2000.103910.1006/meth.2000.1039 ↗
3. 10.1016/j.bios.2015.07.04010.1016/j.bios.2015.07.040 ↗
4. 10.1039/c4cs00369a10.1039/c4cs00369a ↗
5. 10.1002/ange.20170915310.1002/ange.201709153 ↗
6. 10.1039/c7nr08066b10.1039/c7nr08066b ↗
7. 10.1021/acsnano.7b0153610.1021/acsnano.7b01536 ↗
8. 10.1002/anie.20140855810.1002/anie.201408558 ↗
9. 10.1021/acscentsci.7b0058410.1021/acscentsci.7b00584 ↗
10. 10.1039/c7nr09162a10.1039/c7nr09162a ↗
11. 10.1371/journal.pone.000538110.1371/journal.pone.0005381 ↗
12. 10.2174/138527201337480610.2174/1385272013374806 ↗
13. 10.1021/ac402192k10.1021/ac402192k ↗
14. 10.1073/pnas.110535110810.1073/pnas.1105351108 ↗
15. 10.1016/j.tibtech.2010.03.00710.1016/j.tibtech.2010.03.007 ↗
16. 10.1016/j.drudis.2015.02.01310.1016/j.drudis.2015.02.013 ↗
17. 10.4049/jimmunol.170.9.485410.4049/jimmunol.170.9.4854 ↗
18. 10.1158/0008-5472.can-08-203310.1158/0008-5472.can-08-2033 ↗
19. 10.1016/s0022-1759(99)00135-010.1016/s0022-1759(99)00135-0 ↗
20. Dan L. · Cancer Res. · 2001 · 61 · 7002
21. 10.1016/s0022-1759(02)00148-510.1016/s0022-1759(02)00148-5 ↗
22. 10.1158/0008-5472.can-05-106910.1158/0008-5472.can-05-1069 ↗
23. 10.1158/0008-5472.can-04-250010.1158/0008-5472.can-04-2500 ↗
24. 10.1038/nature0887810.1038/nature08878 ↗
25. 10.1021/acs.chemmater.7b0293210.1021/acs.chemmater.7b02932 ↗